Newsletter Archive

  1. 09.12.24 -- Let's Deviate From Deviations - Sterile Drugs. 9/12/2024

    09/12/24 Advancing RNA Newsletter

  2. 09.11.24 -- Is This The Hardest Question Facing mRNA Therapeutics Makers? 9/11/2024
    09/11/24 Advancing RNA Newsletter
  3. 09.04.24 -- Why Bridge RNA Is Taking The RNA Space By Storm 9/4/2024
    09/04/24 Advancing RNA Newsletter
  4. 08.28.24 -- The RNA Challenge Keeping RNA Execs Up At Night 8/28/2024
    08/28/24 Advancing RNA Newsletter
  5. 08.26.24 -- Solutions For mRNA And Nanoparticle Manufacturing 8/26/2024
    08/26/24 Advancing RNA Newsletter
  6. 08.21.24 -- Innovation Advances In mRNA Medicine 8/21/2024
    08/21/24 Advancing RNA Newsletter
  7. 08.21.24 -- Simplifying Preclinical Development And Scale Up Of Lipid Nanoparticles 8/21/2024

    08/21/24 Advancing RNA Newsletter

  8. 08.14.24 -- Ophthalmic Drug Delivery 8/14/2024
    08/14/24 Advancing RNA Newsletter
  9. 08.07.24 -- A "Hot Take" On mRNA CPPs 8/7/2024
    08/07/24 Advancing RNA Newsletter
  10. 07.31.24 -- What Does FDA's Platform Guidance Mean For ATMP Companies? 7/31/2024
    07/31/24 Advancing RNA Newsletter